Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review

Abstract Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved for the treatment of adults with severe AA. As a bet...

Full description

Bibliographic Details
Main Authors: Alexander Egeberg, Louise Linsell, Erin Johansson, Frederick Durand, Guanglei Yu, Sergio Vañó-Galván
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-10-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-023-01044-5